Fig. 3From: The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover studyChange of NT-proBNP values under pimobendan treatment. The post-exercise increase of NT-proBNP values under treatment with pimobendan was significantly attenuated from day 90 to day 180 (p = 0.0452)Back to article page